Syndecan-4 Antibody (336304) [Janelia Fluor® 635]
Novus Biologicals, part of Bio-Techne | Catalog # FAB29181JF635
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
CyTOF-ready, Flow Cytometry
Label
Janelia Fluor 635
Antibody Source
Monoclonal Rat IgG2A Clone # 336304
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Mouse myeloma cell line NS0-derived recombinant human Syndecan-4
Ser20-Glu145
Accession # P31431
Ser20-Glu145
Accession # P31431
Specificity
Detects human Syndecan-4 in direct ELISAs.
Clonality
Monoclonal
Host
Rat
Isotype
IgG2A
Applications for Syndecan-4 Antibody (336304) [Janelia Fluor® 635]
Application
Recommended Usage
CyTOF-ready
Optimal dilutions of this antibody should be experimentally determined.
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: Syndecan-4
Alternate Names
Amphiglycan, Ryudocan, SDC4, Syndecan4
Additional Syndecan-4 Products
Product Documents for Syndecan-4 Antibody (336304) [Janelia Fluor® 635]
Product Specific Notices for Syndecan-4 Antibody (336304) [Janelia Fluor® 635]
Sold under license from the Howard Hughes Medical Institute, Janelia Research Campus.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...